Literature DB >> 28722501

Pediatric endonasal dacryocystorhinostomy: A multicenter series of 116 cases.

WengOnn Chan1,2, Geoff Wilcsek3, Raf Ghabrial4, Robert Alan Goldberg5, Peter Dolman6, Dinesh Selva1,2, Raman Malhotra7.   

Abstract

We report our experience with pediatric endonasal dacryocystorhinostomy (DCR). Multicenter, retrospective, noncomparative study. Cases of pediatric endonasal DCR during 2006-2011 were included from six oculoplastic units. Patients over the age of 16 years were excluded. The outcomes of pediatric endonasal DCR are presented. Indication for surgery, demographics, previous interventions, intraoperative or postoperative complications, follow-up duration, and success rate (defined as significant improvement of epiphora) were evaluated. In total, 116 endonasal DCRs were performed for 103 patients. The mean follow-up period was 8 months (range 3 months to 4 years), with 1 patient lost to follow-up. There were 48 males (mean age 5 years and 9 months) and 50 females (range of 4 months to 16 years), with a total of 98 cases of congenital nasolacrimal duct obstruction (CNLDO) (84.5%) and 18 cases of acquired nasolacrimal duct obstruction (ANLDO) (15.5%). Previous interventions included probing 75.9% (88/116), massaging 43.1% (50/116), and intubation 39.7% (46/116). There were no intraoperative complications. There was one case of postoperative pyogenic granuloma. There were no cases of postoperative infection and postoperative hemorrhage. Ninety percent of procedures were considered successful. Complete symptom resolution was observed in 78% (90/116), significant improvement in 12% (14/116), partial improvement in 2% (2/116), and no improvement in 8% (9/116). In our series, we demonstrated that endonasal DCR is a safe operation and has an overall success rate of 90% for pediatric NLDO.

Entities:  

Keywords:  Dacryocystorhinostomy; endonasal; nasolacrimal duct obstruction; pediatric

Mesh:

Year:  2017        PMID: 28722501     DOI: 10.1080/01676830.2017.1337168

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  2 in total

1.  Management of congenital nasolacrimal duct obstruction: results of a national survey of paediatric and oculoplastic ophthalmologists.

Authors:  Vidushi Golash; Harpreet Kaur; Sarju Athwal; Rebiye Chakartash; Masara Laginaf; Mona Khandwala
Journal:  Eye (Lond)       Date:  2020-09-16       Impact factor: 4.456

2.  Endoscopic dacryocystorhinostomy to treat congenital nasolacrimal canal dysplasia: a retrospective analysis in 40 children.

Authors:  Yan-Hui Cui; Cheng-Yue Zhang; Wen Liu; Qian Wu; Gang Yu; Li Li; Wen-Bin Wei
Journal:  BMC Ophthalmol       Date:  2019-12-03       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.